MOTS-c: can a peptide really boost your metabolism?

MOTS-c is a small peptide made from instructions in mitochondria, the energy centers of cells. In mice it improved insulin sensitivity and physical performance, but it hasn't been tested as a treatment in published human trials. Since October 2026, regulators have said they won't act against licensed pharmacies that compound it under set conditions. For metabolism and blood sugar, options with large human trials already exist.

Reviewed by Darshan Patel, MD, Obesity medicine physician, on 2026-11-12. Next review 2026-12-12.

Book my consultation Video consultations with an Aayu Well physician. Most major insurance accepted, plus convenient cash pay options.

Why people are curious about MOTS-c

MOTS-c has a buzz online as a "metabolism peptide." People look it up hoping for more energy, steadier blood sugar, an easier time losing weight or more stamina in the gym. Researchers first described it in 2015, and in some studies its levels in muscle and blood rise during exercise.

Wanting a metabolism that works with you is a great goal. The real question is whether MOTS-c is the best way to get there.

What the research shows so far

Evidence grade D: early. Most of what we know comes from mice. How we grade evidence.

• In animals: in mice, MOTS-c improved insulin sensitivity, limited weight gain on a high-fat diet, and improved physical performance in older animals.
• In people: studies have measured the body's own MOTS-c levels, but none published so far has tested it as a treatment. HHS reports that a randomized, placebo-controlled trial of a modified version found no serious side effects. That version is a different molecule.
• Still open: whether injected MOTS-c helps weight, blood sugar or fitness in people, the right amount, and what it does over months or years.

Your goal, with stronger evidence behind it

Most people who ask about MOTS-c want one of three things. Here's what has been tested in people.

• Better blood sugar and an easier time with weight. For people living with obesity, GLP-1 medicines such as semaglutide and tirzepatide have been tested in large trials with thousands of people. Under specialist care, they quiet hunger and improve health numbers such as blood sugar.
• More energy and stamina. Strength work twice a week and regular walks build muscle, and muscle is what keeps your metabolism up as the weight comes off.
• Eating that supports your metabolism. Protein at every meal and portions that fit your appetite. At Aayu Well, a registered dietitian helps you turn that into meals you can actually make.

Aayu Elevate™ puts this together: video visits with an obesity medicine physician, a registered dietitian, and medicine when it's right for you. Most major insurance accepted, plus convenient cash pay options. Book my consultation

Is MOTS-c legal now?

Yes, with conditions. In October 2026, HHS said it won't take action against licensed pharmacies and physicians that compound MOTS-c for a specific patient as an injection, as long as they follow ten conditions. FDA had listed it as a safety concern from 2023 until April 2026. This isn't FDA approval, and some states set their own rules. See which peptides can be compounded.

Good to know before you try it

• It isn't FDA-approved, and there's no human safety record for MOTS-c itself yet.
• If you take insulin, other diabetes medicines or a GLP-1, talk to your prescriber first, because MOTS-c may change how your body handles sugar.
• Skip it if you're pregnant or breastfeeding, or if you're an athlete who gets drug tested: the World Anti-Doping Agency prohibits MOTS-c at all times.
• If you use any peptide, get it with a prescription from a licensed pharmacy. Products labeled research use only aren't made or tested for people. Here's why that label matters.

Where Aayu Well stands

We don't prescribe MOTS-c right now. We're following the research and the new pharmacy rules closely, and we review this page every month.

What we can help with today is usually what sits behind the question: weight, blood sugar, energy, sleep and mood. Bring your peptide questions to your first visit. Your physician will give you a straight answer and a plan built around you. You can also see how our weight care works.

Questions people ask

Can I talk to an Aayu Well physician about peptides?

Yes, and we'd encourage it. Bring your questions to your visit. We don't prescribe MOTS-c right now, but your physician will go over the evidence with you, review everything you take, and build a plan for the goal behind the question, whether that's weight, blood sugar, energy or fitness.

Is MOTS-c legal?

As of November 12, 2026, federal regulators say they won't take action when a licensed pharmacy or physician compounds MOTS-c as an injection for a specific patient under ten conditions. It still isn't an FDA-approved drug, and some states set their own rules.

Does MOTS-c help with weight loss?

There's no published human evidence yet; the weight and blood sugar results come from mice. GLP-1 medicines such as semaglutide and tirzepatide, by contrast, have been tested in large trials with thousands of people.

Is MOTS-c safe?

It hasn't been tested as a treatment in people, so its safety is still unknown. HHS reported that a randomized, placebo-controlled trial of a modified version found no serious side effects, but that version is a different molecule.

Can I take it with a GLP-1 like Wegovy or Zepbound?

No studies have looked at the two together. Because MOTS-c may affect blood sugar, talk with your prescriber first if you take diabetes or weight medicines.

Sources

1. HHS: Enforcement Discretion Policy Regarding 503A Compounding Using Certain Peptide Bulk Drug Substances, Appendices A and B (October 2026)
2. Federal Register notice FR Doc. 2026-22192, 91 FR 68526 (October 30, 2026)
3. Lee C, Zeng J, Drew BG, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. 2015;21(3):443-454. doi:10.1016/j.cmet.2015.02.009
4. Reynolds JC, Lai RW, Woodhead JST, et al. MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Nat Commun. 2021;12(1):470. doi:10.1038/s41467-020-20790-0
5. Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med. 2021;384(11):989-1002. doi:10.1056/NEJMoa2032183
6. Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). N Engl J Med. 2022;387(3):205-216. doi:10.1056/NEJMoa2206038
7. World Anti-Doping Agency: 2026 Prohibited List, in force from January 1, 2026 (MOTS-c under S4.4.1, AMPK activators)